In the past year the pharmaceutical industry has witnessed an unprecedented number of drug recalls following the discovery that these products contained impurities, some of which are life threatening.
In his latest article in Pharmaphorum, Dr. Andrew Rut, Co-Founder and CEO of MyMeds&Me, explores the growing challenges of the drug supply chain and argues the clear need for a standard of safety for the Active Primary Ingredients (API's), to curtail the ongoing issue of product recalls in the pharmaceutical industry.
You can read the article here.
